Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00249717 · ClinicalTrials.gov registry record · NA
Group-Based Contingency Management for Substance Abuse Treatment - 1
A NA study, sponsored by UConn Health.
- Completed
- Registry status
- NA
- Development phase
- 312
- Enrollment target
NCT00249717 is a NA study that has completed, run by UConn Health. The registered enrollment target is 312 participants.
The verdict
NCT00249717, a NA study, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 312 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy of prize-based contingency management (CM) when administered exclusively in groups. Substance dependent patients (N=360) at community-based treatment programs are randomly assigned to one of two conditions: (a) standard, non-CM treatment or (b) standard treatment plus prize CM delivered in groups. In the CM condition, patients earn the opportunity to win prizes for attending groups and submitting drug-free biological specimens. Substance use and psychosocial problems are measured at intake, month 1, month 3 (post treatment), and at 6-, 9-, and 12-month follow-up evaluations. We also assess patient characteristics that may be associated with improved outcomes within and across conditions.
Interventions
- BEHAVIORAL Contingency management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 312 participants |
| Start Date | 2005-05 |
| Est. Completion | 2010-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00249717
The ClinicalTrials.gov registry entry for NCT00249717 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 312 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Contingency management is the first listed.
NCT00249717 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00249717 about?
NCT00249717 is a clinical study titled "Group-Based Contingency Management for Substance Abuse Treatment - 1". The purpose of this study is to evaluate the efficacy of prize-based contingency management (CM) when administered exclusively in groups. Substance dependent patients (N=360) at community-based treatment programs are randomly assigned to one of two conditions: (a) standard, non-CM treatment or (b) s...
What is the current status of trial NCT00249717?
This trial is currently completed. It is a NA study. The enrollment target is 312 participants. The study started on 2005-05. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00249717?
The interventions under investigation include: Contingency management (BEHAVIORAL).
Who is sponsoring clinical trial NCT00249717?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.